Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Nature Cancer
|
September 1, 2022
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung
Ana Rita Nobre, Erica Dalla, Jihong Yang, et al.
Journal of Agricultural and Food Chemistry
|
March 19, 2026
Multiomics Analysis across the Life Cycle Identifies Zn<sub>2</sub>Cys<sub>6</sub>_61 as a Target for Enhancing Triterpenoid Production in <i>Ganoderma lucidum</i>
Yihong Li, Liwei Liu, Miaoqing Li, et al.
Mabs
|
June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG
Xiangdan Wang, Valerie Quarmby, Carl Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degeneration
Kelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Nature Communications
|
December 31, 2024
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells
Xianle Shi, Yanjing Li, Hongwei Zhou, et al.
Mabs
|
September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
Nature Communications
|
August 27, 2021
OCT4 cooperates with distinct ATP-dependent chromatin remodelers in naïve and primed pluripotent states in human
Xin Huang, Kyoung-Mi Park, Paul Gontarz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
Annie Ogasawara, James R Kiefer, Herman Gill, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
JCI Insight
|
April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
Karin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Nature Cancer
|
September 1, 2022
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung
Ana Rita Nobre, Erica Dalla, Jihong Yang, et al.
Journal of Agricultural and Food Chemistry
|
March 19, 2026
Multiomics Analysis across the Life Cycle Identifies Zn<sub>2</sub>Cys<sub>6</sub>_61 as a Target for Enhancing Triterpenoid Production in <i>Ganoderma lucidum</i>
Yihong Li, Liwei Liu, Miaoqing Li, et al.
Mabs
|
June 19, 2013
Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG
Xiangdan Wang, Valerie Quarmby, Carl Ng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2014
Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degeneration
Kelly M Loyet, Jeremy Good, Teresa Davancaze, et al.
Nature Communications
|
December 31, 2024
DDX18 coordinates nucleolus phase separation and nuclear organization to control the pluripotency of human embryonic stem cells
Xianle Shi, Yanjing Li, Hongwei Zhou, et al.
Mabs
|
September 7, 2010
Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A Khawli, Sirj Goswami, Ryan Hutchinson, et al.
Nature Communications
|
August 27, 2021
OCT4 cooperates with distinct ATP-dependent chromatin remodelers in naïve and primed pluripotent states in human
Xin Huang, Kyoung-Mi Park, Paul Gontarz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy
Annie Ogasawara, James R Kiefer, Herman Gill, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
JCI Insight
|
April 10, 2020
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody
Karin Staflin, Christina L Zuch de Zafra, Leah K Schutt, et al.
Page
of 17